ArticleFrontiers in oncology2022

Lapatinib Suppresses HER2-Overexpressed Cholangiocarcinoma and Overcomes ABCB1- Mediated Gemcitabine Chemoresistance.

Zhiqing Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.